| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5511VZ6NRQ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| MODULATOR | HLA class II histocompatibility antigen, DRB1-15 beta chain modulator |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108712 |
| FDA SRS | 5511VZ6NRQ |
CONTENTS